We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Experimental Drug Protects Animal Model from Measles-Like Virus

By LabMedica International staff writers
Posted on 04 May 2014
Print article
Image: Ultrastructural appearance of a single measles virus particle as revealed by thin-section transmission electron microscopy (TEM). It is 100–200 nm in diameter, with a core of single-stranded RNA, and is closely related to the rinderpest and canine distemper viruses (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Image: Ultrastructural appearance of a single measles virus particle as revealed by thin-section transmission electron microscopy (TEM). It is 100–200 nm in diameter, with a core of single-stranded RNA, and is closely related to the rinderpest and canine distemper viruses (Photo courtesy of the CDC - [US] Centers for Disease Control and Prevention).
Working with an animal model that mimics measles in humans, a team of molecular virologists have verified that a novel antiviral drug may complement the currently used vaccine and lead to eradication of the disease.

To better study the measles virus under laboratory conditions investigators at Georgia State University (Atlanta, USA) and colleagues at Emory University (Atlanta, GA, USA) and the Paul-Ehrlich Institute (Langen, Germany) used zoonotic Canine distemper virus (CDV), which induces a disease in ferrets with 100% lethality.

The investigators used the ferret model to evaluate the experimental drug ERDRP-0519, which targets the viral RNA polymerase. This enzyme is required for replication of the virus, as it catalyzes the synthesis of a complementary strand of RNA from the original viral RNA template.

Results reported in the April 16, 2014, issue of the journal Science Translational Medicine revealed that prophylactic oral drug treatment of the ferrets protected them from a lethal dose of CDV administered intranasally. Ferrets that received the drug after having been infected with the same dose of virus showed low-grade viral loads, remained asymptomatic, and recovered from infection, whereas control animals succumbed to the disease. Animals that had recovered from CDV infection demonstrated a robust immune response and were protected against re-challenge with a lethal CDV dose.

The investigators stated that the drug is not intended as a substitute for vaccination, but as an additional weapon in a concerted effort to eliminate the disease. "The emergence of strong antiviral immunity in treated animals is particularly encouraging, since it suggests that the drug may not only save an infected individual from disease but contribute to closing measles immunity gaps in a population," said senior author Dr. Richard Plemper, professor in the center for inflammation, immunity, and infection at Georgia State University.

Related Links:

Georgia State University
Emory University
Paul-Ehrlich Institute


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Flu Test
ID NOW Influenza A & B 2
New
Silver Member
Rubella Infection ELISA
ReQuest RUBELLA IgM ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Genome sequencing technology has the potential to detect thousands of genetic disease (Photo courtesy of 123RF)

Gene Technology Outperforms Standard Newborn Screening Tests in Pioneering Study

Since its introduction in the 1960s, newborn screening has grown to encompass dozens of primarily genetic disorders. The standard approach to newborn screening involves detecting specific biomarkers in... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.